華蘭股份(301093.SZ):擬設立合資公司 從事相關設備業務
格隆匯6月3日丨華蘭股份(301093.SZ)公佈,公司近日與上海克來機電自動化工程股份有限公司(簡稱“克來機電”或“克來”)簽訂了《股東協議》。華蘭股份將與克來機電設立一家合資公司(以下簡稱“合資公司”或“公司”),以合資公司作為平台專業從事開發、製造、銷售醫療行業領域內的工業自動化生產系統設備、機電一體化產品及設備、電子控制、設計製造、安裝調試、維修保養等業務。合資公司的註冊資本為300萬元人民幣,華蘭股份將以自有資金出資147萬元人民幣,佔合資公司註冊資本的49%。
本次對外投資是華蘭股份戰略佈局和產業發展的需要,有利於發展華蘭股份新的業務增長點,擴大影響力,促進華蘭股份健康發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.